期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Immune Intervention Effects on the Induction of Experimental Autoimmune Thyroiditis 被引量:5
1
作者 陈伟红 林汉华 王慕逖 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2002年第4期343-345,共3页
To explore im mune intervention effects of the combined use of cycloporin A (Cs A ) and 1,2 5 - dihydroxyvitam in D3[1,2 5 (OH ) 2 D3]at low doses on experimental autoim mune thyroiditis (EAT) ,porcine thyroglobulin... To explore im mune intervention effects of the combined use of cycloporin A (Cs A ) and 1,2 5 - dihydroxyvitam in D3[1,2 5 (OH ) 2 D3]at low doses on experimental autoim mune thyroiditis (EAT) ,porcine thyroglobulin (p TG) was injected into a CBA mouse at the dose of 10 0μg on day 0 and day14 to establish the model of EAT.The immune prevention group from day0 to day2 8, and treatm ent group from day10 to day38were daily adm inistered Cs A(10 mg/ kg) intragastri- cally and/ or1,2 5 (OH) 2 D3(0 .2 μg/ kg) ip.After im munized by p TG,the m ice were sacrificed on day2 8and day38to examine their thyroid gland pathologically,and to check the levels of serum porcine thyroglobulin antibodies (p TGAb) ,porcine thyromicrosom al antibodies (p TMAb) .The incidences of EAT in the immune prevention group and treatment group,with administration of low dose of Cs A and 1,2 5 (OH) 2 D3,were decreased respectively by 4 4 .4 4 % and 37.5 0 % .Those of severe disease in the two groups were decreased respectively by71.4 3% and6 0 .32 % .The levels of serum p TGAb and p TMAb in the imm une prevention group were lower than those of the positive control group.It was concluded thatcombined use of Cs A and1,2 5 (OH) 2 D3at low doses could effectively prevent EAT with a synergic effect. 展开更多
关键词 thyroiditis autoimm une cyclosporin A 1 2 5 (OH) 2 D3
暂未订购
桥本氏病合并甲状腺乳头状腺癌 被引量:9
2
作者 俞建平 陈润浩 +1 位作者 桂律 叶萱光 《中国癌症杂志》 CAS CSCD 2005年第1期16-18,共3页
目的:探讨桥本氏病(HD)合并甲状腺乳头状腺癌(PTC)的发病机理、诊断和治疗.方法:回顾性分析9年间收治的HD合并PTC 12例的临床资料,均行手术治疗,随访.结果:HD合并PTC的患病率为25%(12/48)术前误诊、漏诊达75%,术中快速切片确诊11例,术... 目的:探讨桥本氏病(HD)合并甲状腺乳头状腺癌(PTC)的发病机理、诊断和治疗.方法:回顾性分析9年间收治的HD合并PTC 12例的临床资料,均行手术治疗,随访.结果:HD合并PTC的患病率为25%(12/48)术前误诊、漏诊达75%,术中快速切片确诊11例,术后病理切片确诊l例.全组病例均出现甲状腺结节,根据患者具体情况采取不同范围的甲状腺切除术,3例加行颈淋巴结清扫术.术后病理切片发现颈淋巴结转移3例,术后服用甲状腺素片.所有患者均获随访,随访时间为6个月~8年,患者预后好,无一例死亡、复发或转移.结论:HD可继发PTC.HD合并PTC诊断困难.诊断关键在于充分了解HD和PTC的临床表现,综合运用血清免疫学检查、B超、同位素扫描、细针抽吸细胞学等检查.对怀疑HD合并PTC者应予以手术治疗.术中快速病理切片大多可确诊,手术方式应个体化,术后服用甲状腺素片等. 展开更多
关键词 桥本氏病 甲状腺肿瘤 自身免疫疾病 手术治疗
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部